Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 12Central Nervous System Neoplasms 10Brain Neoplasms 9Astrocytoma 9Oligodendroglioma 8Gliosarcoma 8Glioblastoma 8Lymphoma, Large B-Cell, Diffuse 4Glioma 4Ependymoma 4Multiple Myeloma 3Lymphoma, Follicular 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Medulloblastoma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Hodgkin Disease 2Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Mycosis Fungoides 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia 1Head and Neck Neoplasms 1

Interventions

Temozolomide 5O(6)-benzylguanine 3Vorinostat 2Radiotherapy 2Oxaliplatin 2Lenalidomide 2Cilengitide 2Carboplatin 2veliparib 1tipifarnib 1romidepsin 1pomalidomide 1pazopanib 1ixabepilone 1ispinesib 1cediranib 1becatecarin 1alvocidib 1Verteporfin 1Tamoxifen 1RMP 7 1PT-100 dipeptide 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gelclair 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Optic Nerve Glioma × Carmustine × Clear all
NCT00003765 2013-02-05

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡